Literature DB >> 21383060

The preferred priorities for care document in motor neurone disease: views of bereaved relatives and carers.

Harriet Preston1, Iris Cohen Fineberg, Pauline Callagher, Douglas J Mitchell.   

Abstract

Increasing emphasis is being placed on the need for advanced care planning (ACP) at the end of life. The Preferred Priorities for Care (PPC) document is a patient-held record promoted by the End of Life Care Strategy as an ACP tool to promote discussion and communication amongst patients, family and health care providers. However, little research exists into evaluating its effectiveness or exploring patient and carer views, particularly in non-malignant disease. Because the majority of patients with Motor Neurone Disease (MND) lose verbal communication, early discussion of patients' wishes and preferences, a central aspect of ACP, is vital. This study examined MND patients' bereaved relatives' experiences of using the PPC document and their perceptions about its impact on end-of-life care using qualitative methods. Key findings adding to existing literature were that the PPC document was felt to have little impact on end-of-life care amongst this patient group and that there was a perceived lack of awareness of the document amongst health care professionals (HCPs), in particular hospital staff. This was felt to limit the effectiveness of the document. This has obvious implications for practice, looking at awareness amongst HCPs and ways to improve this situation, particularly in light of the current pressures to meet patient preferences at the end of life.

Entities:  

Mesh:

Year:  2011        PMID: 21383060     DOI: 10.1177/0269216311399664

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  8 in total

1.  Canadian best practice recommendations for the management of amyotrophic lateral sclerosis.

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

2. 

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

Review 3.  Patients experiences of maintaining mental well-being and hope within motor neuron disease: a thematic synthesis.

Authors:  Andrew Soundy; Nicola Condon
Journal:  Front Psychol       Date:  2015-05-12

4.  The Liverpool Care Pathway for the Dying Patient: a critical analysis of its rise, demise and legacy in England.

Authors:  Jane Seymour; David Clark
Journal:  Wellcome Open Res       Date:  2018-04-24

5.  The Role of Palliative Care in Chronic Progressive Neurological Diseases-A Survey Amongst Neurologists in the Netherlands.

Authors:  Hannah A W Walter; Antje A Seeber; Dick L Willems; Marianne de Visser
Journal:  Front Neurol       Date:  2019-01-14       Impact factor: 4.003

Review 6.  End of life care for long-term neurological conditions: A meta-ethnographic review of the experiences of informal carers.

Authors:  Michael Toze; Mo Ray; Thomas George; Kelly Sisson; David Nelson
Journal:  Palliat Med       Date:  2020-11-25       Impact factor: 4.762

Review 7.  Talking about the end of life: communication patterns in amyotrophic lateral sclerosis - a scoping review.

Authors:  Anke Erdmann; Celia Spoden; Irene Hirschberg; Gerald Neitzke
Journal:  Palliat Care Soc Pract       Date:  2022-03-15

Review 8.  Advance Care Planning in Neurodegenerative Disorders: A Scoping Review.

Authors:  Andrea Giordano; Ludovica De Panfilis; Marta Perin; Laura Servidio; Marta Cascioli; Maria Grazia Grasso; Alessandra Lugaresi; Eugenio Pucci; Simone Veronese; Alessandra Solari
Journal:  Int J Environ Res Public Health       Date:  2022-01-12       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.